Global Transcatheter Heart Valve (THV) Market : Trans-catheter Heart valves (THV) are artificial heart valves used to replace the heart valves for treatment of severe aortic stenosis and mitral regurgitation. The heart valve diseases can be congenital or acquired later in life due to older age or lifestyle changes. If these are not treated at the right times it can cause stroke, blood clots, heart failure causing death due to sudden cardiac arrest.
According to WHO, by 2050, the world population of 60 years and above will be total of 2 billion who can suffer from heart valve disease. The trans catheter valve market is growing in sync with the demand of less invasive procedure for patients who are on high risk diseases such as chronic diseases, multiple diseases, etc. however, high cost, risks related to the actual implantation of the trans catheter, misplacement, slipping such technical difficulties can put off the patient and affects the market negatively.
A sample of this report is available upon request @
Trans catheter heart valve (THV) market is categorized as follows-
- Product type
- Trans Catheter Aortic Valve Replacement
- Trans Catheter Mitral Valve Repair
- Surgical procedure
- Transfemoral Approach
- Transapical Approach
- Transaortic Approach
- End user
Hospitals, Ambulatory Surgical centers, Cardiac Catheterization Laboratory
To view TOC of this report is available upon request @
According to the geographical region, the Trans catheter heart valve market is divided into Europe, North America, Asia-Pacific, Middle East & Africa and Latin America. North America dominates the market with over 5 million people only in the U.S. who are diagnosed with heart valve diseases every year. Emerging markets are in Europe and Asia Pacific countries such as China and India which are growing due to increase in patients, technological advancements, etc. Some of important companies are Abbott laboratories (US), Medtronic (US), Edwards Lifesciences Corporation (US) in the Trans catheter heart valve market. In 2017, UDFDA approved Edwards Sapien 3 Trans catheter heart valve which is a heart valve replacement device from Edward Lifesciences Corporation.
Need more information about this report @
The Trans catheter heart valve market is expected to grow significantly due to investments in R & D, technologically advances in the production of prosthetic heart valves will help strengthen the company’s position in the market. More and more companies are becoming part of Trans-catheter heart valve market by focusing on mergers and acquisitions to enhance their market strength. For e.g. Edwards Lifesciences Corporation agreed to promote Valtech Cardio Ltd., for their Trans Catheter repair of mitral and tricuspid valves.
Get access to full summary @
https://www.precisionbusinessinsights.com/market-reports/global-transcatheter-heart-valve-market/
About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.
Contact to Precision Business Insights,
Kemp House,
152 – 160 City Road,
London EC1V 2NX
Email: sales@precisionbusinessinsights.com
Toll Free (US): +1-866-598-1553
Website @ https://www.precisionbusinessinsights.com